Methods of treating transthyretin (TTR) mediated amyloidosis
US11079379B2 · kind B2 · utility
4Cited by
9References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 3, 2018 |
| Grant date | Aug 3, 2021 |
| Priority date | — |
| Expiry date | Jan 11, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/14
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Disclosed herein are methods for reducing or arresting an increase in a Neuropathy Impairment Score (NIS) or a modified NIS (mNIS+7) in a human subject by administering an effective amount of a transthyretin (TTR)-inhibiting composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.